Differential gene expression in vascular smooth muscle cells in primary atherosclerosis and in stent stenosis in humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 12, 2002, Pages 2030-2036

  Zhang, Qi Jun ^a   Goddard, Martin ^b   Shanahan, Catherine ^a   Shapiro, Leonard ^a   Bennett, Martin ^a,b  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Arteriosclerosis; Genes; Restenosis; Smooth muscle; Stents

Indexed keywords

CELL CYCLE PROTEIN; CONTRACTILE PROTEIN;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY STENT; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTIMA; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STENOSIS; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; CAROTID ARTERIES; CAROTID STENOSIS; CELLS, CULTURED; CORONARY VESSELS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RATS; STENTS; TUNICA INTIMA; TUNICA MEDIA;

EID: 0036924249     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000042206.98651.15     Document Type: Article

References (27)

1. Bennett MR, O'Sullivan M. Mechanisms of angioplasty and stent restenosis: Implications for design of rational therapy. Pharmacol Ther. 2001;91:149-166.
2. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988;12:616-623.
3. Garratt KN, Edwards WD, Kaufmann UP, Vlietstra RE, Holmes DRJ. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: Analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol. 1991;17:442-448.
4. Dartsch PC, Voisard R, Betz E. In vitro growth characteristics of human atherosclerotic plaque cells: Comparison of cells from primary stenosing and restenosing lesions of peripheral and coronary arteries. Res Exp Med Berl. 1990;190:77-87.
5. MacLeod DC, Strauss BH, de Jong M, Escaned J, Umans VA, van Suylen RJ, Verkerk A, de Feyter PJ, Serruys PW. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol. 1994;23:59-65.
6. Hoffmann R, Mintz GS, Popma JJ, Satler LF, Pichard AD, Kent KM, Walsh C, Mackell P, Leon MB. Chronic arterial responses to stent implantation: A serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. J Am Coll Cardiol. 1996;28:1134-1139.
7. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S,. Wight TN. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 1994;144:962-974.
8. Matsaura R, Isaka N, Imanaka-Yoshida K, Yoshida T, Sakakur T, Nakano T. Deposition of PG-M/versican is a major case of human coronary restenosis after percutaneous transluminal coronary angioplasty. J Pathol. 1996;180:311-316.
9. Violaris AG, de Jong M, MacLeod DC, Umans VA, Verdouw PD, Serruys PW. Increased extracellular matrix synthesis by smooth-muscle cells obtained from in vivo restenotic lesions by directional coronary atherectomy. Am Heart J. 1996;131:613-615.
10. Patel V, Zhang Q-J, Soos M, Siddle K, Weissberg PL, Bennett MR. Defect in insulin-like growth factor 1 signaling underlies increased apoptosis of human atherosclerotic plaque-derived vascular smooth muscle cells. Circ Res. 2001;88:895-902.
11. Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 1994;22:5640-5648.
12. Tyson K, Shanahan C. Use of cDNA representational difference analysis to identify disease-specific genes in human atherosclerotic plaques. In: Baker A. ed. Methods in Molecular Medicine. Vascular Disease: Molecular Biology and Gene Therapy Protocols. Totowa, NJ: Humana Press Inc; 1999:83-98.
13. Bennett M, Lindner V, DeBlois D, Reidy M, Schwartz S. Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Arterioscler Thromb. 1996;17:2326-2332.
14. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
15. O'Sullivan M, Scott S, Shapiro L, Bennett M. Aberrant cell cycle proliferation in human coronary in stent stenosis provides a target for specific anti-restenotic therapy. Heart. 2002;87:22. Abstract.
16. Ross R, Wight TN, Strandness E. Thiele B. Human atherosclerosis, 1: Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984:114:79-93.
17. Bennett MR, Macdonald K, Chan SW, Boyle JJ, Weissberg PL. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998;82:704-712.
18. Adams LD, Geary RL, McManus B, Schwartz SM. A comparison of aorta and vena cava medial message expression by cDNA CDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res. 2000;87:623-631.
19. Zohlnhofer D, Klein CA, Richter T, Brandi R, Murr A, Nuhrenberg T, Schomig A, Baeuerle PA, Neumann FJ. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FKS06 FK506-binding protein 12 upregulation. Circulation. 2001;103:1396-1402.
20. Zohlnhofer D, Richter T, Neumann F, Nuhrenberg T, Wessely R, Brandl R, Murr A, Klein CA, Baeuerle PA. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell. 2001;7:1059-1069.
21. Faber BC, Cleutjens KB, Niessen RL, Aarts PL, Boon W, Greenberg AS, Kitslaar PJ, Tordoir JH, Daemen MJ. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res. 2001;89:547-554.
22. O'Neill MJ, Sinclair AH. Isolation of rare transcripts by representational difference analysis. Nucleic Acids Res. 1997;25:2681-2682.
23. Kashiwada K, Nishida W, Hayashi K, Ozawa K, Yamanaka Y, Saga H, Yamashita T, Tohyama M, Shimada S, Sato K, Sobue K. Coordinate expression of alpha-tropomyosin and caldesmon isoforms in association with phenotypic modulation of smooth muscle cells. J Biol Chem. 1997;272:15396-15404.
24. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993;73:193-204.
25. 1 chain antisense oligonucleotide. Mech Dev. 1999;89:15-23.
26. Ichii T, Koyama H, Tanaka S, Kim S, Shioi A, Okuno Y, Raines EW, Iwao H, Otani S, Nishizawa Y. Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment. Circ Res. 2001;88:460-467.
27. Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E. Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol Cell Biol. 1999;19:1460-1469.